PE20060881A1 - Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestos - Google Patents
Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestosInfo
- Publication number
- PE20060881A1 PE20060881A1 PE2006000007A PE2006000007A PE20060881A1 PE 20060881 A1 PE20060881 A1 PE 20060881A1 PE 2006000007 A PE2006000007 A PE 2006000007A PE 2006000007 A PE2006000007 A PE 2006000007A PE 20060881 A1 PE20060881 A1 PE 20060881A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- compounds
- triaza
- thia
- dioxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 ES H, ALQUILO C1-C10; R2 ES H, HALOGENO, CIANO, -NR4COR5, -S(O)2R4, ENTRE OTROS; R3 ES ALQUILO C1-C6, ALQUENILO C2-C6, CICLOALQUILO C3-C8, ARILO C6-C11, ENTRE OTROS; R4 Y R5 SON CADA UNO H, ALQUILO C1-C10, ALCOXI C1-C6, ALQUINILO C2-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 4-[4,4-DIOXO-4LAMBDA6-TIA-2,5,9-TRIAZA-1(2,4)-PIRIMIDIN-3(1,3)-BENCENOCICLONONAFAN-15-IL]-N,N-DIMETILBENCEN-SULFONAMIDA; 4-[4,4-DIOXO-4LAMBDA 6-TIA-2,5,9-TRIAZA-1(2,4)-PIRIMIDIN-3(1,3)-BENCENOCICLONONAFAN-15-IL]-BENCENAMINA, 4-[4,4-DIOXO-4LAMBDA6-TIA-2,5,9-TRIAZA-1(2,4)-PIRIMIDIN-3(1,3)-BENCENOCICLONONAFAN-15-IL]-N,N-DIMETILBENCEN-AMIDA; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS INHIBEN LA TIROSIN QUINASA RECEPTORA ENDOTELIAL Tie2 SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON EL CRECIMIENTO VASCULAR DESREGULADO TALES COMO TUMORES SOLIDOS, RETINOPATIA, ARTRITIS REUMATOIDE, PSORIASIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04090509A EP1674470A1 (en) | 2004-12-22 | 2004-12-22 | Sulfonamido-macrocycles as Tie2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20060881A1 true PE20060881A1 (es) | 2006-10-01 |
Family
ID=34928853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000007A PE20060881A1 (es) | 2004-12-22 | 2006-01-03 | Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestos |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1674470A1 (es) |
JP (1) | JP2008524303A (es) |
KR (1) | KR20070099619A (es) |
CN (1) | CN101087798A (es) |
AR (1) | AR052175A1 (es) |
AU (1) | AU2005318361A1 (es) |
BR (1) | BRPI0519268A2 (es) |
CA (1) | CA2590742A1 (es) |
GT (1) | GT200500383A (es) |
IL (1) | IL182834A0 (es) |
NO (1) | NO20073818L (es) |
PA (1) | PA8658001A1 (es) |
PE (1) | PE20060881A1 (es) |
TW (1) | TW200635935A (es) |
WO (1) | WO2006066957A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1870416A1 (en) * | 2006-06-21 | 2007-12-26 | Bayer Schering Pharma Aktiengesellschaft | Sulphonamido-macrocycles as tie2 inhibitors |
EP1873159A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Substituted sulphonamido-macrocycles as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
WO2009132202A2 (en) | 2008-04-24 | 2009-10-29 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
EP2307456B1 (en) | 2008-06-27 | 2014-10-15 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
ES2786552T3 (es) | 2015-09-29 | 2020-10-13 | Bayer Pharma AG | Compuestos de sulfondiimina macrocíclicos nuevos |
ES2819869T3 (es) | 2015-10-08 | 2021-04-19 | Bayer Pharma AG | Nuevos compuestos macrocíclicos modificados |
WO2017060322A2 (en) | 2015-10-10 | 2017-04-13 | Bayer Pharma Aktiengesellschaft | Ptefb-inhibitor-adc |
EP3601236A1 (en) | 2017-03-28 | 2020-02-05 | Bayer Aktiengesellschaft | Novel ptefb inhibiting macrocyclic compounds |
US11254690B2 (en) | 2017-03-28 | 2022-02-22 | Bayer Pharma Aktiengesellschaft | PTEFb inhibiting macrocyclic compounds |
CN115677616A (zh) * | 2021-11-03 | 2023-02-03 | 中国药科大学 | 大环磺酰胺类化合物及其制备方法和医药用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60314500T2 (de) * | 2002-03-01 | 2008-02-07 | Smithkline Beecham Corp. | Diaminopyrimidine und deren verwendung als angiogenesehemmer |
DE10239042A1 (de) * | 2002-08-21 | 2004-03-04 | Schering Ag | Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel |
-
2004
- 2004-12-22 EP EP04090509A patent/EP1674470A1/en not_active Withdrawn
-
2005
- 2005-12-19 CA CA002590742A patent/CA2590742A1/en not_active Abandoned
- 2005-12-19 AU AU2005318361A patent/AU2005318361A1/en not_active Abandoned
- 2005-12-19 CN CNA2005800443140A patent/CN101087798A/zh active Pending
- 2005-12-19 JP JP2007547386A patent/JP2008524303A/ja active Pending
- 2005-12-19 BR BRPI0519268-4A patent/BRPI0519268A2/pt not_active Application Discontinuation
- 2005-12-19 EP EP05820679A patent/EP1844056A2/en not_active Withdrawn
- 2005-12-19 KR KR1020077016661A patent/KR20070099619A/ko not_active Application Discontinuation
- 2005-12-19 WO PCT/EP2005/013957 patent/WO2006066957A2/en active Application Filing
- 2005-12-21 AR ARP050105399A patent/AR052175A1/es not_active Application Discontinuation
- 2005-12-21 TW TW094145438A patent/TW200635935A/zh unknown
- 2005-12-21 GT GT200500383A patent/GT200500383A/es unknown
- 2005-12-22 PA PA20058658001A patent/PA8658001A1/es unknown
-
2006
- 2006-01-03 PE PE2006000007A patent/PE20060881A1/es not_active Application Discontinuation
-
2007
- 2007-04-26 IL IL182834A patent/IL182834A0/en unknown
- 2007-07-20 NO NO20073818A patent/NO20073818L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1844056A2 (en) | 2007-10-17 |
CA2590742A1 (en) | 2006-06-29 |
WO2006066957A3 (en) | 2006-08-31 |
CN101087798A (zh) | 2007-12-12 |
AU2005318361A1 (en) | 2006-06-29 |
KR20070099619A (ko) | 2007-10-09 |
EP1674470A1 (en) | 2006-06-28 |
NO20073818L (no) | 2007-09-21 |
TW200635935A (en) | 2006-10-16 |
JP2008524303A (ja) | 2008-07-10 |
PA8658001A1 (es) | 2006-09-22 |
GT200500383A (es) | 2006-08-03 |
IL182834A0 (en) | 2007-08-19 |
WO2006066957A2 (en) | 2006-06-29 |
BRPI0519268A2 (pt) | 2009-01-06 |
AR052175A1 (es) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20060881A1 (es) | Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestos | |
PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
PE20060589A1 (es) | FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b | |
PE20061096A1 (es) | Derivados de oxiindol como agonistas 5-ht4 | |
NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
NO20063468L (no) | Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister | |
PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
PE20051171A1 (es) | Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo | |
PE20081800A1 (es) | NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA | |
PE20080659A1 (es) | Benzotriazoles como moduladores de quinasas | |
PE20091173A1 (es) | Derivados de heteroarilo como antagonistas de receptor de orexina | |
PE20060336A1 (es) | Compuestos derivados de 1-amino-ftalazina como moduladores de mch1 | |
PE20080068A1 (es) | Compuestos derivados de pirimidina como inhibidores de la quinasa aurora | |
PE20070808A1 (es) | COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA | |
PE20120690A1 (es) | Derivados de 5-fluoropirimidinona | |
AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
PE20130311A1 (es) | Composiciones y metodos para modular la via de senalizacion de wnt | |
PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
PE20080362A1 (es) | Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 | |
DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
AR076460A1 (es) | Antagonistas del receptor cxcr3 | |
PE20060657A1 (es) | Derivados de pirimidina como moduladores de ppar-alfa | |
PE20090482A1 (es) | Derivados heterociclicos como antagonistas del receptor ccr2 | |
PE20060957A1 (es) | Compuestos pirazolopiridinas su preparacion y composiciones farmaceuticas | |
PA8581401A1 (es) | Compuestos de imedazopiridina como agonistas del receptor 5-ht4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |